Literature DB >> 8521520

Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel.

P M Snyder1, M P Price, F J McDonald, C M Adams, K A Volk, B G Zeiher, J B Stokes, M J Welsh.   

Abstract

Liddle's syndrome is an inherited form of hypertension caused by mutations that truncate the C-terminus of human epithelial Na+ channel (hENaC) subunits. Expression of truncated beta and gamma hENaC subunits increased Na+ current. However, truncation did not alter single-channel conductance or open state probability, suggesting there were more channels in the plasma membrane. Moreover, truncation of the C-terminus of the beta subunit increased apical cell-surface expression of hENaC in a renal epithelium. We identified a conserved motif in the C-terminus of all three subunits that, when mutated, reproduced the effect of Liddle's truncations. Further, both truncation of the C-terminus and mutation of the conserved C-terminal motif increased surface expression of chimeric proteins containing the C-terminus of beta hENaC. Thus, by deleting a conserved motif, Liddle's mutations increase the number of Na+ channels in the apical membrane, which increases renal Na+ absorption and creates a predisposition to hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521520     DOI: 10.1016/0092-8674(95)90212-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  105 in total

Review 1.  Ion channels and the control of blood pressure.

Authors:  E H Baker
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

Review 2.  Functional domains within the degenerin/epithelial sodium channel (Deg/ENaC) superfamily of ion channels.

Authors:  D J Benos; B A Stanton
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

3.  Defective regulation of the epithelial Na+ channel by Nedd4 in Liddle's syndrome.

Authors:  H Abriel; J Loffing; J F Rebhun; J H Pratt; L Schild; J D Horisberger; D Rotin; O Staub
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

4.  A single WW domain is the predominant mediator of the interaction between the human ubiquitin-protein ligase Nedd4 and the human epithelial sodium channel.

Authors:  J Shaun Lott; Sarah J Coddington-Lawson; Paul H Teesdale-Spittle; Fiona J McDonald
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

5.  Angiotensin II stimulates epithelial sodium channels in the cortical collecting duct of the rat kidney.

Authors:  Peng Sun; Peng Yue; Wen-Hui Wang
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-14

6.  Loss of protein kinase C inhibition in the beta-T594M variant of the amiloride-sensitive Na+ channel.

Authors:  Y Cui; Y R Su; M Rutkowski; M Reif; A G Menon; R Y Pun
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

7.  The kinase Grk2 regulates Nedd4/Nedd4-2-dependent control of epithelial Na+ channels.

Authors:  Anuwat Dinudom; Andrew B Fotia; Robert J Lefkowitz; John A Young; Sharad Kumar; David I Cook
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-29       Impact factor: 11.205

Review 8.  Regulation and dysregulation of epithelial Na+ channels.

Authors:  Lawrence G Palmer; Ankit Patel; Gustavo Frindt
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

9.  Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel.

Authors:  S Pradervand; P M Barker; Q Wang; S A Ernst; F Beermann; B R Grubb; M Burnier; A Schmidt; R J Bindels; J T Gatzy; B C Rossier; E Hummler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype.

Authors:  F J McDonald; B Yang; R F Hrstka; H A Drummond; D E Tarr; P B McCray; J B Stokes; M J Welsh; R A Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.